FDA Inspection 1280299 — Zhejiang Clairvoyant Pharmaceutical Technology Co., Ltd.
The FDA completed an inspection of Zhejiang Clairvoyant Pharmaceutical Technology Co., Ltd. on July 16, 2025 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 16, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)